好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2004 Annual Meeting | Multiple Sclerosis: Clinical Trials I

Tuesday 04/27/04
02:00 PM - 03:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
MS and Related Diseases
No CME available
Event Timeline
02:00 PM - 03:30 PM Abstract 001 - Effect of Glatiramer Acetate on Primary Progressive Multiple Sclerosis: Initial Analysis of the Completed PROMiSe Trial
02:00 PM - 03:30 PM Abstract 002 - Treatment of Multiple Sclerosis with Daclizumab
02:00 PM - 03:30 PM Abstract 003 - Phase I Trial of CTLA4Ig Treatment in MS
02:00 PM - 03:30 PM Abstract 004 - A Phase II Trial of Mitoxantrone in Patients with Primary Progressive Multiple Sclerosis
02:00 PM - 03:30 PM Abstract 005 - Oral Treatment with Laquinimod Reduces Development of Active MRI Lesions in Relapsing MS
02:00 PM - 03:30 PM Abstract 006 - An Open Label Safety and Tolerability Study of Mitoxantrone Combination Therapy with Either Interferon or Glatiramer Acetate
Faculty Disclosures
Jack P. Antel, MD, FAAN Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities.
Clifford B. Saper, MD, PhD, FAAN Dr. Saper has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. The institution of Dr. Saper has received research support from NIH. The institution of Dr. Saper has received research support from Mathers Foundation. The institution of Dr. Saper has received research support from Tsukuba University. Dr. Saper has received publishing royalties from a publication relating to health care. Dr. Saper has received publishing royalties from a publication relating to health care. Dr. Saper has a non-compensated relationship as a Treasurer with American Neurological Association that is relevant to AAN interests or activities.
Alvaro Pascual-Leone, MD, PhD, FAAN Dr. Pascual-Leone has received personal compensation for serving as an employee of Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magstim. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroelectrics. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TetraNeuron. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Pascual-Leone has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Pascual-Leone has stock in TI Solutions. The institution of Dr. Pascual-Leone has received research support from NIH. The institution of Dr. Pascual-Leone has received research support from NSF. The institution of Dr. Pascual-Leone has received research support from Brightfocus Foundation . Dr. Pascual-Leone has received intellectual property interests from a discovery or technology relating to health care. Dr. Pascual-Leone has received publishing royalties from a publication relating to health care.
Omar A. Khan, MD, PhD No disclosure on file
DeWitt D. Pyburn, MD Dr. Pyburn has nothing to disclose.
Antoaneta J. Balabanov, MD Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen.
Michael D. Fox, MD, PhD Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Erdem Tuzun Erdem Tuzun has nothing to disclose.
No disclosure on file
Brian Edlow, MD Dr. Edlow has received research support from NIH.
George Barrio, MD No disclosure on file
Alexander A. Tarnutzer, MD No disclosure on file
Chen Lin, MD The institution of Dr. Lin has received research support from VA.
Jessica Falco-Walter, MD, FAAN Dr. Falco-Walter has nothing to disclose.
Osama A. Abdel Salam, MD No disclosure on file
Mohammadkazem Bakhshandeh Bali No disclosure on file
Anna Serafini, MD Dr. Serafini has nothing to disclose.
Pranusha Pinna, DO Dr. Pinna has nothing to disclose.
Phong T. Vu, MD Dr. Vu has nothing to disclose.
Diane Lawson No disclosure on file